Features Screener Stocks Charts
Sign In Sign Up

Indoco Remedies Limited Cash Flow Statement

NSE:INDOCO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Free Cash Flow

₹-2.61B

INDOCO's free cash flow was negative at ₹-2.61B in FY 2025, up 3.5% from FY 2024. The company spent more on capital investments than it generated from operations.

Dividend Coverage

-18.8x

INDOCO's free cash flow did not fully cover dividends in FY 2025. The company may be funding dividends from reserves or borrowings.

CapEx Intensity

375.2%

Capital expenditure consumed 375.2% of operating cash flow in FY 2025 for INDOCO, typical of capital-intensive industries.

2-year INDOCO cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 1.24B -753.65M
Cash flow Operating Activities 1.55B 949.27M
Investments in PPE -4.26B -3.56B
Cash flow Investing Activities -4.33B -3.39B
Dividend Paid -207.06M -139.02M
Cash flow Financing Activities 2.80B 2.41B
Cash at beginning of period 109.25M 148.56M
Cash at end of period 148.56M 120.96M
Free Cash Flow -2.71B -2.61B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025